Trials / Completed
CompletedNCT02744560
Effect of Spirulina on Liver Iron Concentration in Beta Thalassemic Children With Hepatitis C
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 6 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
Thalassemics can develop liver fibrosis because of iron overload and hepatitis C infection. The latter is the main risk factor for liver fibrosis in transfusion dependent thalassemics. Excess liver iron is clearly recognized as a co factor for the development of advanced fibrosis in patients with hepatitis virus C infection. Magnetic resonance imaging represents the most available noninvasive technique to assess the level of iron in the liver.there is evidence that suggests Spirulina may help to protect against liver damage, cirrhosis and liver failure in those with chronic liver disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | spirulina | Spirulina in a dose of 250 mg/kg/day will be given orally for 3 months. |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2016-04-20
- Last updated
- 2018-09-11
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02744560. Inclusion in this directory is not an endorsement.